Diabetes and Diabetic nephropathy are prevalent nowadays all over the world with the need for more powerful analytical tools for better identification of pathophysiology, early diagnosis and development of new therapeutic strategies Proteomic analysis especially using mass spectrometry have proven useful for this purpose with many new biomarkers identified